NOVAPRESSIN GLYPRESSIN TELI TERLIP EUROPRESS EUROPRESS

. It is of Synthetic origin and belongs to Peptide. . The Molecular Weight of Terlipressin is 1227.40.

Terlipressin is contraindicated in conditions like Vascular disease.

The severe or irreversible adverse effects of Terlipressin, which give rise to further complications include Cardiac arrhythmias, Angina, Abdominal cramps.Terlipressin produces potentially life-threatening effects which include Bradycardia, Myocardial infarction, Cardiac failure. which are responsible for the discontinuation of Terlipressin therapy.The signs and symptoms that are produced after the acute overdosage of Terlipressin include Hypertension, Increase in BP, Water retention.The symptomatic adverse reactions produced by Terlipressin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Abdominal cramps, Weakness of the leg, Skin pallor.

Terlipressin is primarily indicated in conditions like Bleeding from oesophageal varices, Bleeding oesophageal varices.

No data regarding the interactions of Terlipressin was found.

Drug should not be given to Pregnant Mothers, patients suffering from Liver Malfunction, and Geriatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Ampuls, Vial Store at room temperature. Protect from Sunlight.

Avoid use in patients with chronic nephritis with nitrogen retension. Use with caution and in small doses in patients with vascular disease, especially of coronary arteries. It should be given with care to patients with asthma, migrane, epilepsy, heart failure or hypertension. Fluid retension should be adjusted to avoid hyponatraemia.